What is the recommended treatment for scabies?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Scabies Treatment

Treat scabies with permethrin 5% cream applied to the entire body from the neck down, left on for 8-14 hours, then washed off, with a repeat application in 7-10 days. This is the first-line treatment based on its superior efficacy, safety profile, and cost-effectiveness compared to alternatives 1.

Primary Treatment Regimen

Permethrin 5% cream:

  • Apply to all skin surfaces from the neck down (include face, scalp, and neck in infants and young children)
  • Leave on for 8-14 hours (overnight application is practical)
  • Wash off thoroughly
  • Mandatory repeat application in 7-10 days to kill newly hatched mites
  • More effective when applied as cold cream (refrigerated) for two consecutive days rather than single application 2

Alternative Treatment Options

Oral ivermectin 200 mcg/kg:

  • Reserved for patients who cannot tolerate topical therapy, have failed permethrin treatment, or have crusted scabies 1
  • Must be repeated in 2 weeks due to limited ovicidal activity
  • Take with food to increase bioavailability and epidermal penetration
  • One study showed increased mortality in elderly, debilitated patients, though not confirmed in subsequent reports 1
  • Safe in renal impairment; caution with severe liver disease
  • Not for children <15 kg or <10 years old 3

Lindane 1%:

  • Only use if permethrin fails or patient cannot tolerate it 1
  • Apply thinly from neck down, wash off after 8 hours
  • Significant toxicity concerns: seizures (especially after bathing or with extensive dermatitis), aplastic anemia, neural tube defects in pregnancy 1
  • Contraindications: children <10 years, pregnant/lactating women, extensive dermatitis, immediately after bathing
  • Resistance reported in parts of the United States 1

Critical Management Components

Environmental decontamination:

  • Machine-wash and dry bedding/clothing using hot cycle, or dry-clean
  • Alternatively, remove from body contact for 72 hours minimum
  • Fumigation is unnecessary 1

Contact management:

  • Treat all sexual partners and household contacts from the preceding month simultaneously 1
  • This is essential—failure to treat contacts is a leading cause of treatment failure 4

Common pitfall: Only 32% of patients have close contacts treated appropriately, contributing to persistent disease 5

Special Populations

Infants and young children:

  • Use permethrin only (not lindane or ivermectin) 1
  • Apply to face, scalp, neck, palms, and soles in addition to body 6

Pregnancy and lactation:

  • Permethrin is preferred and safe 1
  • Ivermectin classified as "human data suggest low risk" but permethrin preferred due to more extensive safety data 1
  • Never use lindane: associated with neural tube defects, mental retardation, accumulates in placenta and breast milk 1

HIV/immunocompromised patients:

  • Same treatment as immunocompetent for uncomplicated scabies 1
  • Higher risk for crusted scabies—requires specialist consultation 1

Crusted (Norwegian) Scabies

Combination therapy required:

  • Permethrin 5% cream applied daily for 7 days, then twice weekly until cure
  • PLUS oral ivermectin 200 mcg/kg on days 1,2,8,9, and 15
  • May need additional ivermectin on days 22 and 29 for severe cases 1
  • Never use lindane due to neurotoxicity risk with heavy application 1

Follow-Up and Treatment Failure

Expected timeline:

  • Pruritus may persist up to 2 weeks after successful treatment (allergic dermatitis, not treatment failure) 1
  • Re-evaluate if symptoms persist >2 weeks

Causes of treatment failure:

  • Improper application technique (most common)
  • Failure to treat contacts simultaneously
  • Inadequate environmental decontamination
  • Reinfection from untreated contacts
  • True resistance (increasingly documented but not definitively proven) 4, 5

Management of persistent cases:

  • Verify proper application technique and contact treatment
  • Consider switching to alternative regimen
  • For truly refractory cases: combination permethrin + ivermectin 4

Key Clinical Pearls

  • Application technique matters: Apply to entire body including under nails, between fingers/toes, in skin folds
  • Only 18% of providers treat all contact categories appropriately—this is a major gap 5
  • Dermatology referrals for scabies increased 625% in recent years, largely due to incomplete initial management 5
  • Permethrin is more effective than ivermectin for individual treatment but ivermectin may be superior for mass drug administration in endemic populations 7, 8
  • Keep fingernails trimmed to reduce injury from scratching 1

1

References

Guideline

sexually transmitted diseases treatment guidelines, 2015.

MMWR Recommendations and Reports, 2015

Research

A new treatment regimen with permethrin in scabies.

Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, 2018

Research

Scabies: Epidemiology, Diagnosis, and Treatment.

Deutsches Arzteblatt international, 2021

Research

[Approach to Scabies in Children: An Update].

Acta medica portuguesa, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.